Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

Documenti analoghi

• Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
  di: Juan Jin, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects
  di: Huan Song, et al.
  Pubblicazione: (2025)
• Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
  di: Yuan Liu, et al.
  Pubblicazione: (2025)
• Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
  di: Yongtao Li, et al.
  Pubblicazione: (2024)
• Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions
  di: Yuyan Lei, et al.
  Pubblicazione: (2025)